Page last updated: 2024-10-20

spermidine and Actinic Reticuloid Syndrome

spermidine has been researched along with Actinic Reticuloid Syndrome in 1 studies

Research Excerpts

ExcerptRelevanceReference
"More than one million new skin cancers are diagnosed yearly in the United States creating the need for effective primary and chemopreventive strategies to reduce the incidence, morbidity, and mortality associated with skin cancer."2.70Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. ( Alberts, DS; Bowden, GT; Einspahr, JG; Nelson, MA; Saboda, K; Warneke, J, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Einspahr, JG1
Nelson, MA1
Saboda, K1
Warneke, J1
Bowden, GT1
Alberts, DS1

Trials

1 trial available for spermidine and Actinic Reticuloid Syndrome

ArticleYear
Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:1

    Topics: Aged; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Biopsy; Cell Division; Eflornithine; Enzy

2002